About FBIO Dividend Returns
Fortress Biotech, Inc. (FBIO) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of FBIO over the past year?
Fortress Biotech, Inc. (FBIO) delivered a total return of 117.83% over the past year when dividends are reinvested. The price-only return was 117.83%, meaning dividends contributed an additional 0.00 percentage points to total returns.
Q2How much would $10,000 invested in FBIO be worth today?
A $10,000 investment in Fortress Biotech, Inc. one year ago would be worth $21,783 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $21,783. Dividend reinvestment added $0 to the portfolio value.
Q3Does FBIO pay dividends?
Yes, Fortress Biotech, Inc. (FBIO) pays dividends. In the last year, FBIO paid approximately $0.03 per share in dividends (0.98% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.
Q4Did FBIO beat the S&P 500?
Yes, Fortress Biotech, Inc. (FBIO) outperformed the S&P 500 by 102.38 percentage points over the past year. FBIO delivered a total return of 117.83%, compared to the S&P 500's 15.45%. This 102.38pp alpha means investors in FBIO earned more than a passive S&P 500 index fund.
Q5What is FBIO's worst drawdown?
Fortress Biotech, Inc. (FBIO) experienced a maximum drawdown of -39.00% over the past year, declining from its peak on 2025-09-22 to its trough on 2025-11-03. The stock recovered to its prior peak by 2026-01-02. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is FBIO's long-term total return over 10, 20, or 30 years?
Fortress Biotech, Inc. (FBIO) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -92.0% (-22.3% CAGR) — $10,000 would have grown to $803. Over 20 years: -97.9% total return (-17.6% CAGR) — $10,000 → $207. Over 30 years: -97.9% total return (-12.1% CAGR) — $10,000 → $207. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was FBIO's best and worst year?
Fortress Biotech, Inc.'s best calendar year was 2019 with a total return of 135.8%. Its worst year was 2018 with a total return of -78.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 214.6 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).